WhaleWatch logoWhaleWatch
Sign inStart for ₹1
Smart Money Alert
Alembic Pharmaceuticals Limited logo

Alembic Pharmaceuticals Limited

DecreasedQuarterly
APLLTDPharmaceuticalsMarket Cap₹20K Cr
Stake
1.81% → 1.15%
Holding
22.64 L shares
Change
−12.94 L shares
As of
Jun 2026
Since alert+24.0%₹839.75 → ₹1,040.95
Nifty 50+7.2%
Tata AIA Life Insurance
Tata AIA Life Insurance
Institution
The move

Tata AIA Life Insurance reduced its stake in Alembic Pharmaceuticals from 1.81% to 1.15%, selling 1,293,923 shares.

About Alembic Pharmaceuticals Limited
+ FollowVisit stock

A pharmaceutical company engaged in the development, manufacturing, and marketing of formulations and active pharmaceutical ingredients for domestic and international markets. Alembic Pharma operates three dedicated research and development centers alongside five manufacturing facilities to support its operations across multiple therapeutic areas. The company focuses on producing generic and specialized pharmaceutical products while maintaining vertically integrated operations.

About Tata AIA Life Insurance
+ FollowVisit investor

Joint venture between Tata Sons and AIA Group. AUM crossed Rs 1.3 lakh crore in May 2025, growing 27% YoY, making it one of the fastest-growing equity-oriented insurers in India. CIO Harshad Patil has run the investment book since 2014. Flagship Multi Cap Fund delivered 31.4% CAGR over 5 years, among the strongest performance in the ULIP universe.

Get the next move the moment it happens.
Follow Tata AIA Life Insurance and Alembic Pharmaceuticals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Alembic Pharmaceuticals Limited shareholdersTata AIA Life Insurance's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Alembic Pharmaceuticals Limited
More moves in Alembic Pharmaceuticals Limited
Tata AIA Life InsuranceExited
Tata AIA Life Insurance no longer appears on the Alembic Pharmaceuticals Limited shareholder list, having either exited completely or trimmed its previous 1.15 percent stake below the 1 percent reporting threshold.
16 Oct 2026
Read more
ICICI Prudential Mutual FundIncreased
ICICI Prudential Mutual Fund raised its stake in Alembic Pharmaceuticals from 1.38% to 1.77%, purchasing 7,61,625 shares.
16 Oct 2026
Read more
DSP Mutual FundDecreased
DSP Mutual Fund cut its stake in Alembic Pharmaceuticals from 3.86% to 2.83% by selling 20,25,195 shares.
16 Oct 2026
Read more
DSP Mutual FundDecreased
DSP Mutual Fund sold 1,36,574 shares of Alembic Pharmaceuticals through the open market, trimming its stake from 3.04% to 2.97%.
24 Sept 2026
Read more
ICICI Prudential Mutual FundIncreased
ICICI Prudential Mutual Fund increased its stake in Alembic Pharmaceuticals from 1.12% to 1.38%, buying 505,125 shares.
16 Jul 2026
Read more
See all moves
Tata AIA Life Insurance
More moves by Tata AIA Life Insurance
2newest moves
Members only
Xxxxxx Xxxxxxxxxxxx xxxxxxx xxx xxxxx
Xxxxxxxx Xxxxxxxxxxxx xxxxx xx xxxxxxx
Unlock all 2 moves
Crompton Greaves Consumer Electricals LimitedDecreased
Tata AIA Life Insurance trimmed its stake in Crompton Greaves Consumer Electricals from 1.51% to 1.20%. The insurer sold 19,83,631 shares, reducing its holding to 77,23,893 shares.
CROMPTON21 Oct 2026
Read more
PB Fintech LimitedExited
Tata AIA Life Insurance no longer appears on PB Fintech Limited's latest major shareholder list. The insurer, which previously held a 1.84 percent stake, has either completely exited the stock or trimmed its holding to below the 1 percent reporting threshold.
POLICYBZR21 Oct 2026
Read more
Tata Power Company LimitedDecreased
Tata AIA Life Insurance reduced its holding in Tata Power Company Limited by 1,12,75,242 shares, bringing its position down to 14,750 shares in a near-total exit.
TATAPOWER21 Oct 2026
Read more
See all moves